Exercise produces antidepressant effects through multiple converging mechanisms — increasing monoamine neurotransmitter availability (dopamine, serotonin, norepinephrine) through both acute release and upregulation of synthesis enzymes; reducing cortisol and HPA axis hyperactivation; stimulating BDNF (which is reduced in depression and increased by both exercise and antidepressants); reducing neuroinflammation (elevated in depression); and producing the self-efficacy and positive behavioral activation effects of physical accomplishment — with meta-analyses showing effect sizes for exercise in treating mild-to-moderate depression (Cohen's d ~0.8) comparable to antidepressant medication.
Role
The antidepressant effect of exercise represents one of the most significant and most clinically underutilized findings in psychiatric medicine — with a 2018 meta-analysis of 33 RCTs concluding that exercise had large effect sizes for depression treatment, and a 2016 study showing that 30 minutes of moderate exercise three times weekly was as effective as sertraline for major depressive disorder at 16-week follow-up. Yet exercise is almost never the first-line recommendation for depression in clinical settings, and the majority of people managing depression pharmacologically have never been specifically prescribed a structured exercise protocol with the same specificity as their medication dosing. The exercise prescription gap in depression treatment represents a significant missed opportunity to address one of the most prevalent and most costly conditions in modern healthcare.